Job description
Connecticut based leader in neurological investigative drug therapy seeks an experienced Chief Medical Officer to round on their accomplished executive team and to lead Phase I-III clinical trial efforts.
As the CMO, this person will be pivotal in advancing company’s neurology and spinal cord related clinical development treatments. If you are a effective and committed leader as well as a strategic thinker skilled in effectively utilizing consultants and contract research organizations to conduct clinical studies, this could be an intriguing leadership opportunity to showcase your talents and expertise.
Successful candidates will have a strong track record of success collaborating with colleagues and advancing clinical trials both efficiently and effectively. (ie: Possessing a deep knowledge of Protocol design, experience in working with Key Opinion Leaders and overseeing, implementation, and execution of successful clinical trials.)
MD, MD/PhD with 8+ years of leadership experience in investigational drug development experience in a relevant therapeutic specialty - neurological and/or spinal cord related research projects and medical affairs. Direct expertise in Phase I - III clinical trials, and/or serving as principal investigator with a background in clinical trial design and protocol development. Familiarity with ICH guidelines and FDA requirements. A working knowledge of biostatistics as relevant to the design and analysis of clinical trials and prior experience at senior levels working in and/or leading cross-functional teams
For more information, confidentially apply with a current resume or CV to receive more information or a personal review of your qualifications.
